Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kwality Pharmaceuticals Ltd

NSE: KPL · BSE: 539997 · Pharmaceuticals & Biotechnology · 21 announcements

Kwality Pharmaceuticals Ltd news stories on ALFA NewsRead the news →
Share price
₹3,728.15
Market cap
₹3,868 Cr
Revenue (annual)
₹503.1 Cr
Net profit (annual)
₹67.35 Cr
P/E (TTM)
47.7×Sector 47.4×
Promoter holding
54.86%-0.01% QoQ
FII holding
3.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10:06 IST BSE
Regulatory Approval

Kwality Pharmaceuticals Regulatory Approval

Kwality Pharmaceuticals received CDSCO approval to manufacture pilot batches of Pembroluzimab. This progresses the biologics product from research to the pre-clinical stage.